Member Info for RichGas

Wow....So given the equation below of yours is correct: "If we have a successful phase 2 trial and the analysts are accurate with the $1.7 billion revenue from the subarachnoid haemorrhage market we could be looking at $10+ billion market cap based on a 30% profit margin and 20 times earnings, works out at around £100 per share!" Then the possibility of adding another $4 - 5 billion from the MS market would put this at an credible sp! Is this equate commonly used? If it is...could this be a thousand bagger?!!!

Simple video from the company summarising the the uses of the natural chemical sulforaphane and how they've stabilised a man made version of it. This could be live changing for many from a health and investment perspective and once people become aware I think we are going to see some serious movement in the sp potentially starting monday given today's RNS. From my understanding the markets for SUBARACHNOID HAEMORRHAGE and MS drugs are worth approx $5.5 billion dollars per year and they are also in clinical trials for Breast cancer to assess the potential reversal of resistance to hormone therapy and the impact on clinical benefit. Welcome aboard Edwards. https://youtu.be/PGIoAJ4g2yc

Hi, If it's an open offer consolidated at 100 to 1 what would that mean for someone who has 3.5 million shares at an average of .12? Thanks Rich

I've 3.5 million shares at an average of .12. Could someone kindly explain how they think this open offer may work? Thanks Rich

That's one each then for Amazon, google and facebook who could all seriously monetise this.

Excellent summary from CEO, Dr Stephen Frank https://vimeo.com/148058868

Here's an interesting part of an interview on ************* between TW and AR with some up-to-date info. I now get it and it's all to play for here....very promising. Q: NEW is another of yours but is not a biotech. Is that you spreading risk or just a great opportunity? What exactly does big sofa do? A: It is an opportunity that I believe has a huge potential upside, it was brought to me by somebody I had backed a number of years ago who has a very good track record and he bought 11% of Big Sofa early last year, on that basis I was interested and started doing a lot more DD – what it does and this is a very simplified example is the following: it specialises in video data analysis for major FMCG businesses on a global basis – over the years we have always been asked to fill out surveys either by email or telephone, these are hugely inaccurate – what major brands want is to study customer behaviour via video but converted and tagged to a technology that they are able to access quickly - Big Sofa has developed this technology and is now expanding dramatically on a global customer basis. Q: When might we see some action here? A: We should announce end of September with EGM mid October.

Thanks spmc! Guess I'd better hold then!! I too was expecting a much bigger rise after the fda approval but manage to reduce my average down after investing last year and I'm also surprised given the number of buys v sells today how this has not moved north. However your sums seem to add up and correct me if I'm wrong but it's being trialled for other uses also and if they are succesful would push it way past £100 per share! Exciting times ahead :)

Come on AR, give us an update as to why this is taking so long. My other shares (88e & EVG) have started to fly and I'm hoping NEW will join the party soon. Does anyone know if BS have a USP over other tech co's?

At last I'm above my average. Surely due a rerate Tom and heading north as news gets out :)

Great News! Topped up at 29.5p. Get in now...this will fly IMO.

RNS out: Orphan Designation in the USA in Subarachnoid Haemorrhage Evgen Pharma plc (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, is pleased to announce that the US Food & Drug Administration ("FDA") has granted the Company orphan drug designation for the use of stabilised sulforaphane for the treatment of subarachnoid haemorrhage ("SAH").

http://reut.rs/29ypwbg

Virtualstock is completely different to big sofa! LEG own a percentage of VS and my understanding is it's software saves procurement teams money and if used by big retailers also. Big Sofas software allows clients to manage and tag videos through a sophisticated video library but I believe they are also working on automatically analysing emotions across social media posts and then serving relevant ads based on emotional reactions. So not comparable....however I could be wrong 😉

Can anyone tell me why this link says the conference will happen on July 18/19th and yet the countdown clock to go live further down the page is counting up saying live in 4 days 19 hours? If indeed this is "leading the technology revolution in market research" one would have expected this to be coded correctly do when it reaches July 18th the clock simply stopped. Most odd.

Big hats off to Ben & Gary and all the action group....well done, great work...onwards and upwards

I suggest XTR & 88e.

Did anyone notice this news couple days back? http://www.theguardian.com/media/2016/may/10/amazon-youtube-video-direct

http://www.greenbookblog.org/2014/02/20/iiex-focus-series-technology-market-research-3-of-5-photo-video/

Interesting article...